Pediatrics News

Pregabalin and topiramate significantly reduced the frequency and intensity of migraines in children and adolescents, especially when combined with vitamin supplements, according to a meta-analysis published in JAMA Network Open.

Women who reported experiencing homelessness during the year before giving birth were more likely to have delayed prenatal care and develop hypertension, diabetes and postpartum depression vs. women who reported adequate housing, data show.

BOSTON — Clinicians reviewing smartphone video clips of children sleeping often agreed on Monash Obstructive Sleep Apnea Video Scores, according to data presented at the CHEST Annual Meeting.

ORLANDO — A need for allergy labeling, disparities in epinephrine access and knowledge gaps were found among Head Start centers, according to an abstract presented at the American Academy of Pediatrics National Conference & Exhibition.

Less than 3% of patients tested for a bacterial STI in nearly a dozen EDs were also tested for HIV, demonstrating widespread nonadherence to a CDC recommendation, according to a study presented at IDWeek.

Less than 10% of reproductive aged women with opioid use disorder and hepatitis C virus are treated for HCV, according to findings published in Clinical Infectious Diseases.

SAN ANTONIO — In adolescents with obesity, GLP-1 receptor agonists were associated with lower risk for incident hypertension development 5 and 10 years after initiation vs. other anti-obesity medications, a speaker reported.

SAN ANTONIO — Researchers identified several factors associated with likelihood of obesity drug prescription among youths, including female sex, higher obesity severity, having more comorbidities and older age, a speaker reported.

OpenBiome will continue distribution of investigational fecal microbiota transplantation through 2024, as suspension may put certain patients with recurrent, refractory or fulminant Clostridioides difficile at risk, according to the AGA.

The FDA on Monday cleared Qiagen’s 1-hour PCR test for meningitis and encephalitis, which the company said could help treat meningococcal disease more quickly.